Table 4.
Compounds | IC50 (μM) |
---|---|
1 | >50 |
2 | 22.3 ± 5.0 |
3 | 13.1 ± 6.8 |
4 | 13.9 ± 7.5 |
5 | 21.9 ± 9.8 |
6 | >50 |
7 | 32.2 ± 5.7 |
8 | 17.8 ± 4.9 |
9 | 7.6 ± 2.0 |
10 | 3.6 ± 2.2 |
11 | 8.4 ± 2.2 |
Indometacin a | 32.1 ± 2.5 |
a Positive control.
Compounds | IC50 (μM) |
---|---|
1 | >50 |
2 | 22.3 ± 5.0 |
3 | 13.1 ± 6.8 |
4 | 13.9 ± 7.5 |
5 | 21.9 ± 9.8 |
6 | >50 |
7 | 32.2 ± 5.7 |
8 | 17.8 ± 4.9 |
9 | 7.6 ± 2.0 |
10 | 3.6 ± 2.2 |
11 | 8.4 ± 2.2 |
Indometacin a | 32.1 ± 2.5 |
a Positive control.